Latest filing published 14 Aug 2018 for Avadel Pharmaceuticals PLC, €69k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael S. Anderson: trading record in brief
Michael S. Anderson appears in our data through filings on Avadel Pharmaceuticals PLC shares, published by SEC (Form 4). We count 19 filings; the first trade dates from 14 March 2016 and the latest from 10 August 2018.
The open-market side counts 11 purchases for €406k alongside 1 sale for €69k. The net balance comes to €336k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 6 share grants. Since January 2018: 2 purchases and 1 sale on the market.
A typical purchase (the median) is worth €33k. On 7 out of 11 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 14 August 2018 came the latest disclosure, an open-market sale for €69k in Avadel Pharmaceuticals PLC. The latest purchase dates back some time: it was published 3,057 days ago, on 27 June 2018. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael S. Anderson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,297 shares@ US$4.9150.9% of flowADSsSEC:0001144204-18-044801:0
- 2,500 shares@ US$6.049.5% of flowADSsSEC:0001140361-18-030201:0Canonical exit: 24 Sept 2018 (T+90)
- 3,000 shares@ US$6.443.5% of flowADSsSEC:0001140361-18-026052:0Canonical exit: 22 Aug 2018 (T+90)
- 25,000 shares0ADSsSEC:0001140361-17-046224:0
- 5,000 shares@ US$8.867.9% of flowADSsSEC:0001140361-17-045703:0Canonical exit: 7 Mar 2018 (T+90)
- 4,000 shares@ US$9.806.9% of flowADSsSEC:0001140361-17-035536:0Canonical exit: 11 Dec 2017 (T+90)
- 2,500 shares@ US$10.004.7% of flowADSsSEC:0001140361-17-021796:0Canonical exit: 17 Aug 2017 (T+90)
- 223,250 shares0ADSsSEC:0001140361-17-001853:0
- 223,250 shares0ADSsSEC:0001144204-17-000316:0
- 223,250 shares0ADSsSEC:0001144204-17-000131:0
- 18,000 sharesADSsSEC:0001140361-16-090077:0
- 30,000 sharesADSsSEC:0001140361-16-090136:0
- 2,000 shares@ US$10.644.2% of flowADSsSEC:0001140361-16-087612:0Canonical exit: 19 Feb 2017 (T+90)
- 2,000 shares@ US$14.125.3% of flowADSsSEC:0001144204-16-123136:0Canonical exit: 1 Dec 2016 (T+90)
- 5,000 shares@ US$14.3013.3% of flowADSsSEC:0001144204-16-120578:0Canonical exit: 20 Nov 2016 (T+90)
- 50,000 sharesADSsSEC:0001144204-16-118823:0
- 5,000 shares@ US$8.848.2% of flowADSsSEC:0001144204-16-102684:0Canonical exit: 10 Aug 2016 (T+90)
- 5,000 shares@ US$11.0410.3% of flowADSsSEC:0001144204-16-089108:0Canonical exit: 16 Jun 2016 (T+90)
- 10,000 shares@ US$9.7418.4% of flowADSsSEC:0001144204-16-088514:0Canonical exit: 12 Jun 2016 (T+90)
19 of 19 declarations